Skip to main content
logo
Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
0.9194
+0.0340 (3.84%)
At close: Aug 20, 2026, 4:00 PM EDT
0.9194
0.00 (0.00%)
After-hours: Aug 20, 2026, 4:35 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Developing and Commercializing Innovative Therapeutics
236.20M160.18M194.62M292.48M211.65M
Total
236.20M160.18M194.62M292.48M211.65M

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
236.20M160.18M194.62M292.48M211.65M
Total
236.20M160.18M194.62M292.48M211.65M